FDA Import Refusal 1FX-3000427-0/20003/1 — Sun Pharma
The FDA refused shipment 1FX-3000427-0/20003/1 from Sun Pharma (India) on Sep 14, 2026. The refused product falls under Drugs and Biologics — NAPROXEN (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 14, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GDY49 NAPROXEN (ANTI-INFLAMMATORY)
- Charges
- 75